SP 500 Inches Higher as Healthcare and Tech Lead Utilities Lag Sebi Uncovers PumpandDump Scheme Across 82 SME Stocks Rs 2025 Crore Impounded Indian InvITs Sector Seeks Streamlined MA Rules to Attract Broader Investor Base Wall Streets Overlooked Bear Market Signal What Investors Need to Know Certificate of Deposit Rates Remain Attractive Lock in up to 4 APY as of May 24 2026 Oil Prices Decline on Optimism Over Potential USIran Peace Deal Strait of Hormuz Reopening YCBD Q1 2026 Earnings EPS Misses Estimates Stock Declines FENG Q3 2024 Earnings Net Loss Deepens as Advertising Headwinds Persist ATLCZ Q1 2026 Earnings Strong EPS Beat Amid Stable Operations IPW Q3 2025 Earnings Narrow Loss Misses Estimates Stock Rises on Resilience AVD Q3 2025 Earnings Significant EPS Miss Amid Challenging Conditions XWEL Q3 2023 Earnings Significant EPS Miss with No Reported Revenue Cellyan Biotechnology HKPD Slumps 783 Key Support at 050 Under Pressure Forum Energy Technologies FET Slides 239 Amid Sector Weakness Key Support Levels in Focus National Beverage Corp FIZZ Posts Modest Gain Amid Technical Consolidation Cloudastructure Inc CSAI Gains 7 as Shares Test Key Resistance Level Eagle Point Institutional Income Fund Preferred Shares EIIA Hold Steady Near 25 Amid Low Volatility Gentell CEO Navigates Oil Price Volatility Amid Strait of Hormuz Crisis RNGR Q1 2026 Earnings EPS Miss Weighs on Shares as Revenue Details Remain Unclear Title Eastern Company EML Holds Steady at 2126 as Support and Resistance Levels Remain Key EBS Q1 2026 Earnings EPS Surprises 183 Above Estimates Amid Strong Operational Execution BBLG Q1 2026 Earnings NarrowerthanExpected Loss as Company Advances Bone Graft Platform TFII Q1 2026 Earnings EPS Beats Estimates by Double Digits AGCO Q1 2026 Earnings Strong Profit Beat Bolsters Investor Sentiment After Challenging Quarter Ross Stores ROST Q1 2026 Earnings EPS Surges Past Estimates Despite Muted Revenue Disclosure CENT Q1 2026 Earnings Profitability Surprise Lifts Confidence Despite Flat Revenue Disclosure ImageneBio IMA Q1 2026 Earnings WiderthanExpected Loss as PreRevenue Biotech Advances Pipeline